Consensus SCHOTT Pharma AG & Co. KGaA Deutsche Boerse AG

Equities

1SXP

DE000A3ENQ51

Real-time Estimate Tradegate Other stock markets 06:19:23 2024-06-03 am EDT			5-day change	1st Jan Change
28.72 ^EUR	-1.91%		-4.87%	-14.50%

May. 28	SCHOTT PHARMA : Berenberg reiterates its Neutral rating	ZD
May. 21	Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	DP

Evolution of the average Target Price on SCHOTT Pharma AG & Co. KGaA

Price target over the last 5 years

History of analyst recommendation changes

a3d94a9330631.bBVH-BfGf_Ck23hVLHSb-Jtu0_SCzdOSzAlVtYG0Jfk.PUMVgXKLKpmQvzkhVATZn-E7p7yxnL7I_lwy_-3SSJQuT3WXYPAQqMupFw~ca1b7815912d7cc53315507de55995e7

Analyst Recommendations on SCHOTT Pharma AG & Co. KGaA

SCHOTT PHARMA : Berenberg reiterates its Neutral rating	May. 28	ZD
Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	May. 21	DP
SCHOTT PHARMA : Receives a Buy rating from Deutsche Bank	May. 21	ZD
UBS lowers target for Schott Pharma to 33 euros - 'Neutral'	May. 20	DP
SCHOTT PHARMA : UBS reiterates its Neutral rating	May. 20	ZD
Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight'	May. 15	DP
SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating	May. 15	ZD
SCHOTT PHARMA : Barclays remains Neutral	May. 15	ZD
Schott Pharma falls sharply - 'High dependence on end markets'	May. 15	DP
SCHOTT PHARMA : Gets a Neutral rating from UBS	May. 15	ZD
SCHOTT PHARMA : Jefferies reiterates its Neutral rating	May. 14	ZD
UBS starts Schott Pharma with 'Neutral' - Target 40 euros	May. 14	DP
SCHOTT PHARMA : UBS from Sell to Neutral	May. 14	ZD
SCHOTT PHARMA : Buy rating from Deutsche Bank	May. 13	ZD
SCHOTT PHARMA : Gets a Neutral rating from Barclays	May. 10	ZD
SCHOTT PHARMA : Jefferies remains Neutral	Apr. 22	ZD
Berenberg starts Schott Pharma with 'Hold' - Target 38 Euro	Mar. 27	DP
SCHOTT PHARMA : Berenberg remains Neutral	Mar. 27	ZD
SCHOTT PHARMA : Jefferies reiterates its Neutral rating	Mar. 18	ZD
SCHOTT PHARMA : Buy rating from Deutsche Bank	Mar. 04	ZD
Barclays rates Schott Pharma at 'Equal Weight' - Target 30 euros	Feb. 29	DP
SCHOTT PHARMA : Barclays reiterates its Neutral rating	Feb. 29	ZD
SCHOTT PHARMA : Jefferies sticks Neutral	Feb. 29	ZD
Deutsche Bank raises target for Schott Pharma to 42 euros - 'Buy'	Feb. 15	DP
SCHOTT PHARMA : Buy rating from Deutsche Bank	Feb. 15	ZD